Form 4 Tracker
Kaitlyn Arsenault

Chief Financial Officer · 1 filing · Latest: Feb 6, 2026

Skye Bioscience, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
SKYE
ARSENAULT KAITLYN—Nov 15, 2024
Proposed Sale
$5.5157,084$314.5K—